[14] Clinical characteristics [edit] FHI is characterized by hypoglycemia that ranges from severe neonatal-onset, difficult-to-manage disease to childhood-onset disease with mild symptoms and difficult-to-diagnose hypoglycemia
There is no pharmacopeial monograph, no standardized dose, and no regulatory floor on quality, so price tracks form factor, advertised purity, and how much active material is in the package
A randomized, placebo-controlled, single and multiple dose study of intravenous thymosin beta-4 in healthy volunteers
Description This DSIP nasal spray supplies delta sleep-inducing peptide (molecular formula C35H48N10O15, molecular weight 848.81 g/mol), a nonapeptide first isolated in 1977, as a ready-to-use intranasal solution for laboratory research